FOAMed Resources: How to Consume, Curate and Create

Resources for learners and educators to engage in digital health professional education can include tools and strategies that maximize the power of FOAMed – Free Open Access Medical Education. Mike Paddock, MD shares some online resources that are easy to navigate in this video.

How do you consume, curate and create FOAMed? Share in the comments.

Future of Medical Education: What is FOAMed?

The Office of Health Professional Education is working together with a community of clinical educators in Minnesota, who will join forces and develop a new architecture for the medical education of the future. The first Digital Health Professions Education 2.0 Consume, Create and Curate conference will be held on Aug. 17, at the Regions Hospital Auditorium.

So what does medical education of the future look like? Where does one get started? What is digital health professions education?

We would like to contribute to the discussion by starting a conversation about FOAMed. Mike Paddock, a panelist at the upcoming conference introduces FOAMed in the video below:


[People] Welcome, 2017-2019 Medical Toxicology Fellows!

The Office of Health Professional Education is excited to welcome the 2017-2019 fellows who will join our Medical Toxicology fellowship program based at Regions Hospital. The program is a collaborative effort between HealthPartners Institute and Regions Hospital, Hennepin County Medical Center (HCMC), and the Hennepin Regional Poison Center (HRPC). The program has been accredited by the ACGME since 2005 and received a 5-year accreditation in 2008.


[Community of practice] Cheryl Magnuson-Giese on practice-ready

Panelist Cheryl Magnuson Giese, MSW/MPH., SPHR, discusses what Practice Ready means at the 2016 Community of Practice event.

What will practice ready mean in 2020?


 Building Trust: More Oxytocin, Less Epinephrine

ICE Blog

By Felix Ankel, MD @felixankel and Leah Hanson, PHD @lrbhanson

“Trust is like the air we breathe. When it’s present, nobody really notices. But when it’s absent, everybody notices.” Warren Buffett

You are a new #MedEd dean charged with modernizing and integrating a postgraduate education program into a recently merged health care delivery system.  The new organizational structure is built on past structures that emphasize authority/accountability and resources/responsibilities gaps.  How do you navigate this environment? How do you build the necessary trust networks to accelerate change?

Most health care and educational systems have organizational charts that describe formal structures and lines of authority.  However, much of the work done in any system is influenced by informal “advice”, trust, and communication networks that operate independent of the “org chart”.  An essential skill of a #MedEd leader is to build an effective trust network.

Theories behind trust…

View original post 587 more words

Generic Drug Prices Rising: What is the solution?

By: Jon Alpern, M.D. and Bill Stauffer, M.D., M.S.P.H.

US spending on prescription drugs continues to be a significant component of healthcare spending. According to IMS data, $373.9 billion was spent in 2014, which was a 13.1% increase.1 Brand name specialty drugs account for much of this. The introduction of generic versions into the market should allow for significant cost savings to payers, however recently some generic drugs have skyrocketed in price.This has left patients relying on these medications vulnerable.In our article: – t=article we describe how decreased competition within the generic market can lead to high prices, and highlight the case of albendazole as an example of exploitative pricing in circumstances where a natural monopoly has formed.2

As we examine solutions to the problem of high generic drug costs, more research is needed to determine where price hikes are occurring and the extent of the problem. Importantly, this issue has garnered attention by lawmakers, and a congressional hearing was held in November, 2014.3 A bill was introduced by Senator Sanders proposing that generic drug manufacturers pay a rebate to Medicaid when the price of a generic drug increases beyond inflation.4 By request of Senators Cummings and Sanders, the Department of Health and Human Services Inspector General will also be investigating the extent of the problem further.5

Perhaps of greatest interest to providers, and what should have important policy implications, is the effect that rising generic drug costs is having on decision-making at the patient and provider level. When the cost of a medication suddenly increases, how are patients and providers responding? Are they attempting to acquire their medications from foreign sources either through importing or via internet/mail? Are they not filling their prescription at all? We believe the answers to some these questions may be sobering but will help determine the true scope of the problem and the appropriate policy solutions.


  1. Medicines Use and Spending Shifts: A Review of the Use of Medicines in the U.S. in 2014. Imshealth. Available at:
  2. Alpern, JD, WM Stauffer, and AS Kesselheim. “High-cost generic drugs–implications for patients and policymakers.” The New England journal of medicine 371.20 (2014):1859-62.
  3. “Why are Generic Drugs Skyrocketing in Price?” Subcommittee on Primary Health and Aging. Thursday, November 20, 2014. Available at:

Jon Alpern was recently featured on ABC’s nightline story: ABC US News | World News